2.7.11.30	(1'R,5'S,6'S)-2-(3',5'-dibromo-1',6'-dihydroxy-4'-oxocyclohex-2'-enyl) acetonitrile	the small dibromotyrosine derivative purified from Pseudoceratina sp. suppresses TGF-beta responsiveness by inhibiting TGF-beta type I receptor serine/threonine kinase activity. The compound inhibits the TGF-beta-stimulated transcriptional activations of 3TP-Lux and decreases phosphorylated Smad2/3 levels and the nuclear translocation of Smad2/3 increased by TGF-beta. The compound inhibits TGF-beta-induced EMT and wound healing of A-549 cells and is a potential therapeutic agent for fibrotic disease and cancer treatment. The compound has no effects on TGF-beta receptor synthesis but attenuates TGF-beta-induced transcriptional activation in Mv1Lu cells and TGF-beta-induced expression of fibronectin and PAI-1 in A549 and NMuMG cells and TGF-beta-induced cell migration	217786	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-(6-ethylpyridin-2-yl)ethanone	-	146099	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-(6-methylpyridin-2-yl)ethanone	-	146100	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-bromo-2-(6-ethylpyridin-2-yl)ethanone	-	146101	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-bromo-2-(6-methylpyridin-2-yl)ethanone	-	146102	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-bromo-2-pyridin-2-ylethanone	-	146103	
2.7.11.30	1-(1,3-benzodioxol-5-yl)-2-pyridin-2-ylethanone	-	146104	
2.7.11.30	2,6-lutidine	i.e. 2,6-dimethylpyridine	146944	
2.7.11.30	2-(6-ethylpyridin-2-yl)-1-quinoxalin-6-ylethanone	-	146168	
2.7.11.30	2-(6-methylpyridin-2-yl)-1-quinoxalin-6-ylethanone	-	146169